hydroxyurea has been researched along with Purpura, Thrombocytopenic, Idiopathic in 1 studies
Purpura, Thrombocytopenic, Idiopathic: Thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases IMMUNOGLOBULIN G autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute (affecting children) and chronic (adult) forms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schloemer, N | 1 |
| Lozovatsky, M | 1 |
| McClain, R | 1 |
| Kent, P | 1 |
1 other study available for hydroxyurea and Purpura, Thrombocytopenic, Idiopathic
| Article | Year |
|---|---|
Sustained remission of Chronic Immune Thrombocytopenic Purpura with low dose hydroxyurea.
Topics: Adult; Chronic Disease; Female; Humans; Hydroxyurea; Platelet Count; Purpura, Thrombocytopenic, Idio | 2011 |